Founded in December 2021, Medataccess Technology is headquartered in Chengdu, with employees in Beijing, Shanghai, Guangzhou, Shijiazhuang, Wuhan, Hainan, Hong Kong, and North Carolina；is a healthcare big data technology company based in China and serving the world, integrating medical services, statistics, real world study, evidence from health economics and market access strategy. Medataccess follow international standards and provide customers with full life cycle medical data solutions. Our mission is medicine as the core, data as the foundation, health as the goal, and result as the guide and we strive to be a one-stop lifecycle data partner for healthcare Industry.
Dr. Hu Hao holds double Master degree both in Biostatistics and Bioinformatics from the University of Leuven, Belgium, and PhD in Health Economics from the University of Newcastle.15 years of experience in Biostatistics and clinical trials (phase I-IV) and economic evaluation of observational studies. He has worked in large multinational pharmaceutical companies and CRO companies such as Novo Nordisk, Quintiles, Servier, and Gilead. He has extensive experience in pharmaceutical R&D, market access and product commercialization.
Ms. Li has 17 years of experience in clinical trial data management and team management. She has been the head of data management in IQVIA and Rundo Pharmaceuticals, as well as in multinational pharmaceutical companies such as Merck Sharp, Merck Serono and Ferring Pharmaceuticals. She has extensive experience in clinical trial data management, clinical data project management and team management. Her data science related experience covers multiple therapeutic areas, including database construction, data management, and real-world research.
Ms. Guo has 13 years of working experience in medical affairs and has worked in CSPC and PEDATA. She has been engaged in drug research and clinical trials. She was mainly responsible for pre-marketing and post-marketing medical strategy formulation, clinical research design, medical supervision, medical writing, clinical research implementation and management. She is experienced in participating in major national projects. She has extensive (phase I-IV) tumor and anti-infection project management experience.